Free Trial
→ Top Trader Reveals Stunning Black Friday Deal (From Base Camp Trading) (Ad)tc pixel Free SMIF Stock Alerts

TwentyFour Select Monthly Income Fund (SMIF) Competitors

TwentyFour Select Monthly Income Fund logo
GBX 82.70 +0.20 (+0.24%)
As of 11:54 AM Eastern
Compare

SMIF vs. GROW, JFJ, BPCR, EDIN, and GSS

Should you buy TwentyFour Select Monthly Income Fund stock or one of its competitors? TwentyFour Select Monthly Income Fund's main competitors and comparable companies include Molten Ventures (GROW), JPMorgan Japanese (JFJ), BioPharma Credit (BPCR), Edinburgh Investment (EDIN), and Genesis Emerging Markets Fund (GSS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does TwentyFour Select Monthly Income Fund compare to Molten Ventures?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Molten Ventures (LON:GROW) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Molten Ventures has a net margin of 75.09% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Molten Ventures' return on equity of 9.21% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Molten Ventures 75.09%9.21%-3.46%

15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. Comparatively, 40.9% of Molten Ventures shares are owned by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are owned by company insiders. Comparatively, 1.6% of Molten Ventures shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

TwentyFour Select Monthly Income Fund has higher earnings, but lower revenue than Molten Ventures. Molten Ventures is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.68N/A£5.7514.38
Molten Ventures£148M7.59-£33.58M£69.009.52

In the previous week, TwentyFour Select Monthly Income Fund had 1 more articles in the media than Molten Ventures. MarketBeat recorded 2 mentions for TwentyFour Select Monthly Income Fund and 1 mentions for Molten Ventures. TwentyFour Select Monthly Income Fund's average media sentiment score of 0.00 equaled Molten Ventures'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TwentyFour Select Monthly Income Fund
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Molten Ventures
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Molten Ventures has a consensus target price of GBX 708.67, suggesting a potential upside of 7.86%. Given Molten Ventures' stronger consensus rating and higher probable upside, analysts plainly believe Molten Ventures is more favorable than TwentyFour Select Monthly Income Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TwentyFour Select Monthly Income Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Molten Ventures
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

TwentyFour Select Monthly Income Fund has a beta of 0.657, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Molten Ventures has a beta of 1.9564402, suggesting that its share price is 96% more volatile than the broader market.

Summary

Molten Ventures beats TwentyFour Select Monthly Income Fund on 10 of the 14 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to JPMorgan Japanese?

JPMorgan Japanese (LON:JFJ) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

JPMorgan Japanese pays an annual dividend of GBX 8.70 per share and has a dividend yield of 1.1%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.5%. JPMorgan Japanese pays out 5.8% of its earnings in the form of a dividend. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

JPMorgan Japanese has higher revenue and earnings than TwentyFour Select Monthly Income Fund. JPMorgan Japanese is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan Japanese£245.55M4.63£194.81M£149.065.22
TwentyFour Select Monthly Income Fund£17.70M17.68N/A£5.7514.38

JPMorgan Japanese has a beta of 1.024, indicating that its share price is 2% more volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its share price is 34% less volatile than the broader market.

JPMorgan Japanese has a net margin of 96.52% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. JPMorgan Japanese's return on equity of 20.00% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan Japanese96.52% 20.00% 8.06%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

18.9% of JPMorgan Japanese shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.1% of JPMorgan Japanese shares are owned by insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, TwentyFour Select Monthly Income Fund had 2 more articles in the media than JPMorgan Japanese. MarketBeat recorded 2 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for JPMorgan Japanese. JPMorgan Japanese's average media sentiment score of 0.00 equaled TwentyFour Select Monthly Income Fund'saverage media sentiment score.

Company Overall Sentiment
JPMorgan Japanese Neutral
TwentyFour Select Monthly Income Fund Neutral

Summary

JPMorgan Japanese beats TwentyFour Select Monthly Income Fund on 8 of the 13 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to BioPharma Credit?

TwentyFour Select Monthly Income Fund (LON:SMIF) and BioPharma Credit (LON:BPCR) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.5%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 709.9%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BioPharma Credit pays out 73.4% of its earnings in the form of a dividend. BioPharma Credit is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, TwentyFour Select Monthly Income Fund had 2 more articles in the media than BioPharma Credit. MarketBeat recorded 2 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for BioPharma Credit. BioPharma Credit's average media sentiment score of 1.39 beat TwentyFour Select Monthly Income Fund's score of 0.00 indicating that BioPharma Credit is being referred to more favorably in the news media.

Company Overall Sentiment
TwentyFour Select Monthly Income Fund Neutral
BioPharma Credit Positive

TwentyFour Select Monthly Income Fund has a beta of 0.657, suggesting that its share price is 34% less volatile than the broader market. Comparatively, BioPharma Credit has a beta of 0.22688746, suggesting that its share price is 77% less volatile than the broader market.

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. Comparatively, 31.8% of BioPharma Credit shares are held by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are held by insiders. Comparatively, 0.1% of BioPharma Credit shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

BioPharma Credit has a net margin of 89.20% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. BioPharma Credit's return on equity of 9.39% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
BioPharma Credit 89.20%9.39%4.98%

BioPharma Credit has higher revenue and earnings than TwentyFour Select Monthly Income Fund. BioPharma Credit is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.68N/A£5.7514.38
BioPharma Credit£110.03M0.10£10.42B£9.540.10

Summary

BioPharma Credit beats TwentyFour Select Monthly Income Fund on 9 of the 14 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Edinburgh Investment?

Edinburgh Investment (LON:EDIN) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Edinburgh Investment has higher revenue and earnings than TwentyFour Select Monthly Income Fund. TwentyFour Select Monthly Income Fund is trading at a lower price-to-earnings ratio than Edinburgh Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edinburgh Investment£79.43M13.35£180.50M£55.9115.67
TwentyFour Select Monthly Income Fund£17.70M17.68N/A£5.7514.38

Edinburgh Investment pays an annual dividend of GBX 30.20 per share and has a dividend yield of 3.4%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.5%. Edinburgh Investment pays out 54.0% of its earnings in the form of a dividend. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, TwentyFour Select Monthly Income Fund had 2 more articles in the media than Edinburgh Investment. MarketBeat recorded 2 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for Edinburgh Investment. Edinburgh Investment's average media sentiment score of 0.42 beat TwentyFour Select Monthly Income Fund's score of 0.00 indicating that Edinburgh Investment is being referred to more favorably in the media.

Company Overall Sentiment
Edinburgh Investment Neutral
TwentyFour Select Monthly Income Fund Neutral

9.7% of Edinburgh Investment shares are owned by institutional investors. Comparatively, 15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.4% of Edinburgh Investment shares are owned by company insiders. Comparatively, 0.1% of TwentyFour Select Monthly Income Fund shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Edinburgh Investment has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.657, suggesting that its share price is 34% less volatile than the broader market.

Edinburgh Investment has a net margin of 89.72% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Edinburgh Investment's return on equity of 7.03% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Edinburgh Investment89.72% 7.03% 6.69%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

Summary

Edinburgh Investment beats TwentyFour Select Monthly Income Fund on 10 of the 14 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Genesis Emerging Markets Fund?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Genesis Emerging Markets Fund (LON:GSS) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.5%. Genesis Emerging Markets Fund pays an annual dividend of GBX 0.17 per share. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Genesis Emerging Markets Fund pays out 0.1% of its earnings in the form of a dividend.

Genesis Emerging Markets Fund is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.68N/A£5.7514.38
Genesis Emerging Markets Fund£250.40M0.00N/A£140.70N/A

In the previous week, TwentyFour Select Monthly Income Fund had 2 more articles in the media than Genesis Emerging Markets Fund. MarketBeat recorded 2 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for Genesis Emerging Markets Fund. TwentyFour Select Monthly Income Fund's average media sentiment score of 0.00 equaled Genesis Emerging Markets Fund'saverage media sentiment score.

Company Overall Sentiment
TwentyFour Select Monthly Income Fund Neutral
Genesis Emerging Markets Fund Neutral

15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

TwentyFour Select Monthly Income Fund has a net margin of 57.51% compared to Genesis Emerging Markets Fund's net margin of 0.00%. TwentyFour Select Monthly Income Fund's return on equity of 5.95% beat Genesis Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Genesis Emerging Markets Fund N/A N/A N/A

Summary

TwentyFour Select Monthly Income Fund beats Genesis Emerging Markets Fund on 7 of the 10 factors compared between the two stocks.

Get TwentyFour Select Monthly Income Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMIF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMIF vs. The Competition

Export
MetricTwentyFour Select Monthly Income FundCapital Markets IndustryFinance SectorLON Exchange
Market Cap£313.07M£5.35B£14.14B£2.84B
Dividend Yield13.41%5.52%4.88%5.10%
P/E Ratio14.3824.7120.4823.37
Price / Sales17.687.664.845.03
Price / CashN/A29.7220.3220.23
Price / BookN/A1.801.812.45
Net IncomeN/A£419.50M£1.33B£5.88B
7 Day Performance1.22%0.09%0.03%0.83%
1 Month Performance-1.78%-1.95%-0.68%-1.81%
1 Year Performance-5.16%-1.94%4.71%7.19%

TwentyFour Select Monthly Income Fund Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMIF
TwentyFour Select Monthly Income Fund
N/AGBX 82.70
+0.2%		N/A-5.4%£313.07M£17.70M14.38N/A
GROW
Molten Ventures
1.1667 of 5 stars		GBX 645.50
-0.4%		GBX 708.67
+9.8%		+55.4%£1.18B£148M9.3620
JFJ
JPMorgan Japanese
N/AGBX 753
-1.2%		N/A+5.9%£1.15B£245.55M5.05N/A
BPCR
BioPharma Credit
N/AGBX 0.99
+0.4%		N/A+9.5%£1.09B£110.03M0.10N/A
EDIN
Edinburgh Investment
N/AGBX 854
-1.4%		N/A+6.0%£1.06B£79.43M15.27N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SMIF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...
Crypto 101 Media | Sponsoredtc pixel